This cluster is driven by passive index rebalancing, not active conviction. Monitor for active fund 13F filings in coming weeks to gauge genuine institutional interest.
SYRE drugs
SYRE drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $80.77entry
- T+1 · 5mo ago +0.02%α −0.52% · $80.79
- T+5 · 5mo ago +8.32%α +7.89% · $87.49
- T+20 · 4mo ago +22.26%α +20.37% · $98.75
- T+60 · 2mo ago +10.16%α +5.77% · $88.98
How similar events traded
Executive Summary
Four mega-passive institutional investors (Vanguard, BlackRock, State Street, Fidelity) collectively added $468.9M in SYRE during Q4 2025, increasing their combined holdings to $768.5M. The buying is dominated by index-fund rebalancing rather than active conviction, and the sole seller (Morgan Stanley) trimmed a small position. The cluster reflects passive index weight adjustments following SYRE's significant market cap growth, not a fundamental thesis change.
Key Financial Metrics
Institutional Positions
Net institutional flow: $468.9M
▲ Buyers (4)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Fidelity | ADD | +28.5% | $381.3M | $229.4M |
| BlackRock | ADD | +38.7% | $180.9M | $114.2M |
| Vanguard | ADD | +32.3% | $132.2M | $81.1M |
| State Street | ADD | +26.8% | $74.1M | $44.2M |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -45.4% | $5.6M | $376.0K |
Key Facts
- 4 mega-passive funds added $468.9M in aggregate, bringing total holdings to $768.5M
- Fidelity led with a $229.4M increase (28.5% share growth), now holding $381.3M
- BlackRock added $114.2M (38.7% share growth), now at $180.9M
- Vanguard added $81.1M (32.3% share growth), now at $132.2M
- State Street added $44.2M (26.8% share growth), now at $74.1M
- Morgan Stanley trimmed 45.4% of its position but value increased $376K due to price appreciation
- All five funds are mega-passive/index managers, zero active or activist funds participated
- The cluster reflects passive index rebalancing, not active investment thesis
Financial Impact
4 passive funds accumulated $468.9M in new SYRE positions; 1 passive fund trimmed a small position with net value increase of $376K
Risk Factors
- All buyers are passive/index funds, no active manager signal to validate the thesis
- 13F data is 45+ days stale; positions may have been unwound since quarter-end
- Morgan Stanley's trim, while small, is the only non-buying signal in the cluster
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-SYRE-2025-Q4 |
Track record
36 reports on SYRE
8 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +54.27% at T+60 after the Apr 13, 2026 report. 15 of 21 went positive at some point.
Filters
- Nov 3, 202613d ago 8-K Neutral 5/10 No price data
- Nov 3, 202613d ago Press Release Bearish 5/10 Entry $99.04 settles Feb 2
- Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $85.90 settles Jan 7
- Oct 9, 20265w ago SC 13D/A Neutral 3/10 Entry $85.90 settles Jan 7
- Oct 7, 20265w ago 8-K Bearish 5/10 Entry $80.85 settles Jan 4
- Oct 6, 20265w ago 424B5 Bearish 6/10 Entry $80.85 settles Jan 4
- Oct 5, 20266w ago Press Release Bearish 6/10 Entry $80.11 settles Dec 31
- Oct 5, 20266w ago 424B5 Bearish 5/10 Entry $80.11 settles Dec 31
- Oct 5, 20266w ago Press Release Bearish 5/10 Entry $80.11 settles Dec 31
- Oct 2, 20266w ago Insider Cluster Bearish 4/10 Entry $92.72 settles Dec 30
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers